Background: Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system. Few studies focused on the relationship between septicemia and MS. Aim: To evaluate the potential impact of septicemia on risk for MS. Design: Two cohorts of patients with septicemia and without septicemia were followed up for the occurrence of MS. Methods: Patients of 482 790 with septicemia was enrolled from the National Health Insurance Research Database between 2001 and 2011 as the study group to match the 1 892 820 individuals, as the control group, by age and gender. Incidence of MS in both groups was calculated. Cox proportional-hazards regressions were performed for investigating hazard ratios (HR) for MS between groups. Results: Septicemia patients had a 3.06-fold (95% CI: 2.16-4.32, P < 0.001) greater risk of developing MS than the matched group. In addition, higher severity of septicemia was associated with higher risk of developing MS (moderate: HR ¼ 4.03, 95% CI: 2.53-6.45, P < 0.001; severe: HR ¼ 11.1, 95% CI: 7.01-17.7, P < 0.001). Similar results also occurred in both male and female patients with septicemia (male: HR ¼ 4.06, 95% CI: 2.17-7.58, P < 0.001; female: HR ¼ 2.72, 95% CI: 1.79-4.11, P < 0.001). Patients without counterpart comorbidities had a significantly higher risk of MS than the controlled group (HR ¼ 3.02, 95% CI: 2.10-4.35, P < 0.001).
Introduction
Septicemia, characterized by the presence of micro-organisms or their toxins in the blood circulation, is a severe and even lifethreatening clinical condition. It leads to extensive systemic inflammatory responses and enhanced production of inflammatory cytokines, which are requirements for fighting infection, despite overzealous response can result in tissue injury, organ failure and ultimately death. 1, 2 Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system, characterized by clinical exacerbation, inflammation, demyelinated plaques in the brain and spinal cord. 3 It is believed that inflammation is an important pathogenetic factor in MS that the extent of axonal injury correlates with the degree of inflammation. 4 Despite these acknowledged pathophysiological precepts, the role of septicemia in the development of MS has not been investigated for a long time.
We conducted a retrospective nationwide, population-based cohort study of MS in a large population of incident Taiwan septicemia patients in order to clarify whether septicemia is a risk factor for MS. The relatively large sample size and long follow-up period of this study population permitted simultaneous adjustment of many potential confounders, such as patient age, gender and comorbidities, that might influence the risk of MS in this population.
Materials and methods

Database
The data utilized in this study was retrieved from the entire National Health Insurance (NHI) claims-based database in Taiwan for the period between 2001 and 2011. 5 The NHI system, launched in 1995, is an imperative social insurance scheme that provides comprehensive health care coverage to Taiwan's 23 million citizens. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) is the diagnostic coding system for disease adopted by the NHI. The Bureau of the NHI indiscriminately audits the medical records to validate the claims for diagnosis and treatment. The diagnosis without evidentiary clinical findings may be regarded as a health care fraud by NHI with a punishment up to 100-fold of the reimbursement claimed by the clinical physician or treating hospital. Former studies have shown the reliability of the diagnosis coding. 6, 7 Taiwanese government gave a scrambled and anonymous number before releasing data for research to safeguard the privacy of the insured people. Because the data is de-identified, the informed consent of participants was waived. This study was approved by China Medical University Institute Review Board [CMUH104-REC2-115(CR-2)].
Study population
The study group comprised all patients who had been hospitalized due to septicemia based on ICD-9-CM codes 038, 036.2 and 003.1 for the first time from 2001 to 2011. In the septicemia cohort, the first day of septicemia diagnosis was recognized as the index date. We excluded cases with a previous diagnosis of MS (ICD-9-CM codes 340) or with lacking identification of sex from our study. Finally, 482 790 patients were identified as the study cohort. We randomly selected 1 892 820 individuals with a ratio of 4 : 1, to match the septicemia group according to age and gender. Each case was then traced from the index date up to the day of MS development. For cases who did not suffer a MS, the endpoint of tracking was the final day of the study period (31 December 2011 
Statistical analysis
Comparisons between two groups were analysed using the Student's t-test for continuous variables and the Pearson chisquare test for categorical variables such as age groups, gender, systemic lupus erythematosus, depression, peripheral vascular disorders, deficiency anemias, rheumatoid arthritis, fluid and electrolyte disorders, smoking and infectious mononucleosis. P < 0.05 was considered statistically significant. The incidence density of MS was compared between groups by dividing the total number of MS events into the sum of follow-up period (per 10 000 person-years). Cox proportional hazard regressions were employed to evaluate the adjusted hazard ratio (HR) for the influence of septicemia on developing MS after adjustment for the mentioned variables. Kaplan-Meier analysis was performed to estimate the cumulative incidence of MS for these two groups. The impact of severity of septicemia on MS risk was also evaluated. The definition of septicemic severity based on two methods: (i) the length of hospital stay at the first admission due to septicemia, and (ii) the proportion of length of hospital stay due to septicemia: dividing the length of stay due to septicemia during the study period by the total length of follow-up duration. 8 By using the tertile method, septicemia severity was further classified as mild (the first tertile in the septicemia severity), moderate (the second tertile in the septicemia severity) and severe (the third tertile in the septicemia severity). 9 Statistical Package for SAS software version 9.4 (SAS Institute Inc., Cary, NC) was administered for all statistical analyses.
Results
In this study, we identified 482 790 patients diagnosed with septicemia and 1 892 820 age-and gender-matched controls for comparison ( Figure 1 ). The demographic features displayed in Table 1 . Results of the multi-variate Cox proportional hazards regression analysis after adjustment of age, gender and comorbidities to determine the HR of MS among the septicemia and control group are shown in Table 2 . The incidence of MS in the septicemia group was 3.36 vs. 0.73 per 100 000 person-years in the control cohort. Patients with septicemia had higher risks of developing MS compared to the controlled cohort (HR ¼ 3.06, 95% CI: 2.16-4.32, P < 0.001). Kaplan-Meier analysis revealed that significantly higher cumulative incidence of MS in the septicemia group than in the matched controls (log rank test, P < 0.0001; Figure 2 ). To investigate the impact of severity of septicemia on the incidence of MS, we divide the septicemia patients into groups based on hospitalization length and severity: mild, moderate and severe. Multi-variate Cox proportional hazards regression for adjusted HR was used. We found an increasing trend for developing MS with increasing hospitalization length (P for trend <0.0001). Results revealed that HRs of MS risk were 2.04 (95% CI: 1.09-3.79, P < 0.001), and 3.44 (95% CI: 2.39-4.95, P < 0.001) for the hospitalization length ranged from 1 to 5 days and more than 5 days, respectively, after adjustment for sex, age and medical comorbidities. Similarly, compared to comparisons, the moderate and severe septicemia groups were likely to develop MS (moderate: HR ¼ 4.03, 95% CI: 2.53-6.45, P < 0.001; severe: HR ¼ 11.1, 95% CI: 7.01-17.7, P < 0.001). The higher HR of developing MS among the three sub-groups corresponded to the following order: severe, moderate and mild (P for trend <0.0001; Table 2 ).
To examine whether septicemia is an age-dependent risk factor for MS, we divided patients into three groups by age (<45, 45-64 and 65 years). The septicemia group had significantly greater risk for development of MS than the control cohort in the sub-group with age <45 and 65 years (age <45 years: adjusted HR ¼ 4.77, 95% CI: 2.89-7.86, P < 0.001; age 65 years: adjusted HR ¼ 2.55, 95% CI: 1.16-5.62, P < 0.05). However, no significant difference was found between the septicemia group and matched controls in the sub-group aged 45-64. We also investigated if septicemia is a gender-dependent risk factor for MS using the Cox regression analysis. The results revealed that both female and male patients with septicemia had higher risk Comorbidity-specific analysis showed that septicemia patients had a significantly higher risk of MS than the controlled group for study without counterpart any comorbidities (adjusted HR ¼ 3.02, 95% CI: 2.10-4.35, P < 0.001; Table 3 ).
Discussion
MS is one of the most common neurological disorders in young adults frequently leading to permanent long-term disability, affecting over 2.5 million people worldwide. 10 In spite of improvement in diagnosis and treatment, the pathogenesis of MS remains elusive. MS is presumptively resulted from an exogenous trigger in genetically susceptible individuals, contributing to inflammation, demyelination and neurodegeneration.
11
Our cohort study showed that the patients with septicemia were at higher risk for development of MS after adjustment of age, gender and medical comorbidities. Meanwhile, the severity of septicemia had a proportional impact on the incidence of MS. The sub-group analysis revealed that both female and male patients with septicemia were associated with an increased risk of MS. The incidence of MS was higher in septicemia patients without medical comorbidities than in individuals without septicemia. HR, hazard ratio; Severity of septicemia ¼ (total length of hospital stay due to septicemia during the follow-up duration)/(length of follow-up duration); T1, the first tertile; T2, the second tertile; T3, the third tertile.
a
The length of hospital stay at the first admission due to septicemia. ***P < 0.001. Previous studies documented geographic and racial differences in the prevalence, clinical presentation and outcomes of MS. 12 MS is generally reported to be more prevalent in women than men. 13 In this study, we found that higher MS incidence 15 Lately, high dietary salt intake is also proposed to be an environmental risk factor for auto-immune diseases development through the induction of pathogenic T-helper 17(Th17) cells, recognized as critical immune cells in the pathogenesis of MS. 16, 17 In the current study, we also found that the impact of septicemia on MS development was higher for men than for women (male: HR ¼ 4.06, 95% CI: 2.17-7.58, P < 0.001; female: HR ¼ 2.72, 95% CI: 1.79-4.11, P < 0.001). Sex-specific differences between the male and female immune and nervous systems, genetic and epigenetic or environmental-related effects, the effects of gonadal hormones as well as maternal and fetal interactions were thought to play a significant role in development and progression of MS differently in men and women. 18 Several possible mechanisms might underlie the higher MS risk among patients with septicemia. During severe sepsis, disseminated intravascular coagulation, characterized by systemic activation of blood coagulation, leads to diffuse formation of microvascular thrombi in various organs as well as hemorrhages due to subsequent exhaustion of coagulation factors. The devastating consequence is multi-organ dysfunction eventually. 19 Intracranial infarctions or hemorrhages taking place in the white matter tracts result in disconnection of distant brain areas and diminished effectiveness of neuronal networks. These alterations might conduce to white matter abnormalities, which have been observed by magnetic resonance imaging in patients with acute sepsis and sepsis survivors. 20 Furthermore, mitochondrial dysfunction during sepsis is postulated to be another factor influencing brain function. Previous studies showed oxygen consumption is enormously decreased in critically ill patients regardless of normal or even increased tissue oxygen availability, resulting in multiple organ failure and death. 21 Brain mitochondrial dysfunction has been observed in animal models of sepsis. 22 Meanwhile, mitochondrial dysfunction may continue in survivors of severe sepsis. 23 Combination of reactive oxygen species (ROS) generation in sepsis and attenuated mitochondrial turnover might be the main cause for mitochondrial dysfunction. 24, 25 As mentioned above, the complex relationship between focal hypoperfusion and decreased oxygen consumption result in a complicated phenotype after acute and chronic sepsis, recognized as sepsisassociated encephalopathy. 26 The role of mitochondrial dysfunction in auto-immune disorders is not well understood. Adenosine triphosphate depletion and mitochondrial damage were documented as triggers of lymphocyte apoptosis in systemic lupus erythematosus. 27 An interesting observation of mitochondrial dysfunction in MS was lately demonstrated. Lassmann et al. proposed that inflammation in MS triggers mitochondrial injury and incapability of the brain to maintain neuronal network. 28 The origin of mitochondrial injury is radicals resulted from a consequence of inflammation in MS. 29 There was also evidence that oxidative stress contributed to down-regulation of synaptic plasticity genes and up-regulation of stress-response genes in the brain where inflammationinduced changes were found. 30 In summary, these findings demonstrated systemic inflammation results in substantial challenges to the cerebral energy supply that compromises brain connectivity. In addition, Th17 cells, a lineage of CD4þ T helper cells, are currently well known modulators of immunity. Sepsis possesses extensive systemic effects, many of which influence the molecular mechanisms that regulate Th17 immunity. 31 Researches about experimental auto-immune encephalomyelitis and MS have demonstrated a significant role of Th17 cells in the pathogenesis of auto-immune, inflammatory and demyelinating diseases. 32, 33 Recent study also exhibited an expansion of peripheral Th17 cells can enter brain parenchyma and injure cells, is correlated with MS disease activity. 17 Taken together, recent evidence showed that genetic, molecular and environmental components were linked to the chronic brain dysfunction of systemic inflammation. In this study, we found that the risk for development of MS was significantly greater in the septicemia group with age <45 and 65 years, HR, hazard ratio.
*P < 0.05; ***P < 0.001.
instead of the middle-aged (45-to 64-year) sub-group with septicemia, suggesting that age was not an absolute risk factor for developing MS in individuals with septicemia. Furthermore, the incidence of MS was higher in septicemia patients without medical comorbidities than in individuals without septicemia, reinforcing that septicemia is a potential risk factor for MS, especially in individuals without MS comorbidities.
Study limitations
Certain limitations should be taken into account when interpreting the results. Firstly, information of family history, environmental factors, such as sun exposure, vitamin D supplements and cigarette smoking are difficult to ascertain from the NHI research database; however, these factors may have an impact on MS risk. 34 Secondly, the diagnosis of septicemia, MS and comorbidities were according to the ICD-9-CM codes recorded in the database from Taiwan NHI program, which may vary from study to study. The Taiwan NHI administration has a cross-checking system to judge the accuracy of declared information from different hospitals. Thirdly, in order to explore if septicemia is associated with following increased risk for development of MS, we only recruited patients with new incidences of MS and septicemia. However, data from huge database may also include unrecognized recurrent individuals who may have had MS and septicemia before 1996 when NHI was started. In addition, some cases of bacteremia may be managed on an outpatient basis. Finally, our results only displayed an association rather than straightforward relationship between septicemia and MS. Further investigation will be required to provide a deeper insight into the mechanism underlying the association showed in the present study.
Conclusion
Septicemia was linked to a greater risk of developing MS in our study. Patients who had suffered increased severity of septicemia had a higher risk for the development of MS after surviving. These results suggest that precautionary strategies of MS could be strengthened by aggressively preventing and treating septicemia as well as keep the promise to improve quality of life and reduce long-term disability of surviving patients with septicemia.
